US reflects on idea of technology cost forum
This article was originally published in Clinica
An article in the January-February issue of the prestigious US health policy journal Health Affairs calls for the creation of a "national forum" to track the adoption, use and eventual outcomes from new capital investments in medical technology areas such as digital radiology and haemofiltration.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.